![](/img/cover-not-exists.png)
Class I HDAC inhibitors display different anti-tumor mechanism in leukemia and prostatic cancer cells depended on their p53 status
Li, Xiaoyang, Peterson, Yuri K., Inks, Elizabeth S., Himes, Richard, Li, Jiaying, Zhang, Yingjie, Kong, Xiujie, Chou, C. JamesLanguage:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/acs.jmedchem.8b00136
Date:
March, 2018
File:
PDF, 2.00 MB
english, 2018